Home » Topics » BioWorld Science

BioWorld Science
RSS

Cancer vaccine VEGFC-Vax induces lymphangiogenesis for melanoma immunotherapy

April 6, 2021

Phase II data reported for GV-1001 in moderate to severe Alzheimer's disease

April 6, 2021

Phase III trial investigates TQB-2450 with anlotinib for advanced biliary cancer

April 6, 2021

Tsukushi protein mutations can lead to hydrocephalus

April 1, 2021

FDA approves Roszet to treat elevated LDL-C in primary nonfamilial hyperlipidemia and HoFH

April 1, 2021

Celon reports phase I data on second-generation GPR40 agonist CPL-280

April 1, 2021

U.S. approval for Sarclisa with Kd for relapsed or refractory multiple myeloma

April 1, 2021

Yingli reports phase II topline data on linperlisib in relapsed or refractory follicular lymphoma

April 1, 2021

China's NMPA approves Ayvakit for GIST with PDGFRA exon 18 mutation

April 1, 2021

Qinlock approved in China for advanced GIST

April 1, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...